CTIS2023-506167-34-00进行中（未招募）1 期
Improving inpatient GHB detoxification with baclofen: A proof of concept and dose-finding study. - PaNaMa ID: 114633
Stichting Radboud University Medical Center0 个研究点目标入组 28 人开始时间: 2023年7月7日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- •Diagnosed with GUD according to the DSM-V-TR criteria of substance use disorder, Indication for intramural GHB detoxification, GHB use >50ml/day, >18 years old
排除标准
- •Patients who has acute psychiatric co-morbidity that require immediate medical attention and interferes with the execution of the study, such as mania, delirium and psychosis, Physical contra-indications for baclofen, Body weight <55kg, Insufficient understanding of the Dutch language, GHB use >120ml/day, Comorbid benzodiazepine use >30mg diazepam equivalent per day, Use of antihypertensive drugs, Use of tricyclic antidepressant drugs
研究者
相似试验
进行中（未招募）
1 期
Improving inpatient GHB detoxification with baclofeGHB use disorderCTIS2023-506167-34-02Stichting Radboud University Medical Center28
进行中（未招募）
1 期
Improving GHB withdrawal with baclofen.GHB/GBL Withdrawal SyndromeEUCTR2013-005319-28-GBCentral and North West London NHS Foundation Trust7
已完成
不适用
Improving GHB withdrawal with baclofeTopic: Mental HealthSubtopic: AddictionsDisease: Addictions, Addictive Substances– illegal drugsMental and Behavioural DisordersGHB/GBL withdrawal syndromeISRCTN59911189Central and Northwest London NHS Foundation Trust (UK)7
已完成
不适用
Baclofen as relapse prevention in the treatment of Gamma-hydroxybutyrate (GHB) dependence: an open label study.NL-OMON39314Mental Health Care and Addiction Services (GGZ Nederland)/National program Scoring Results100
招募中
不适用
Baclofen as treatment for relapse in GHB abuseNL-OMON24379ijmegen Institute for Scientist-Practitioners in Addiction (NISPA)/ Mental Health Care and Addiction Services (GGZ Nederland)/National program Scoring Results100